Lymphatic Filariasis

Early Detection and AI-Based Management of Skin-Related Neglected Tropical Diseases in Sub-Saharan Africa by Frontline Health Workers

Moxidectin for LF, Cote d'Ivoire (DOLF)

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

Better Options for Lymphatic Filariasis Treatment

Lymphatic Filariasis (LF) in Ivory Coast

Adjunctive Ivermectin Mass Drug Administration for Malaria Control

Mass Drug Administration for Lymphatic Filariasis and Onchocerciasis for Liberia

A 24 Month Study to Compare Efficacy of Doxycycline vs Placebo for Improving Filarial Lymphedema in India

A 24 Month Study, to Compare the Efficacy of Doxycycline vs. Placebo for Improving Filarial Lymphedema in Mali

A 24 Month Study to Compare Efficacy of Doxycycline vs Placebo for Improving Filarial Lymphedema in Sri Lanka

Death to Onchocerciasis and Lymphatic Filariasis (DOLF) Triple Drug Therapy for Lymphatic Filariasis

Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis

Spontaneous Antigenemia in Loiasis

Twice Yearly Treatment for the Control of LF

Optimization of MDA With Existing Drug Regimens for LF: Monitoring Efficacy of Ongoing Treatment Programs in PNG

PK PD Study of IDA and Azithromycin for NTDs ( ComboNTDs )

Repeat Ivermectin Mass Drug Administrations for Control of Malaria: a Pilot Safety and Efficacy Study

Eval 3-Drug Therapy Diethylcarbamize, Albendazole and Ivermectin That Could Accelerate LF Elimination Outside of Africa

Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis for Ivory Coast (DOLF-Ivory Coast)

Effect of Albendazole Dose on Clearance of Filarial Worms